Product Images Losartan Potassium
View Photos of Packaging, Labels & Appearance
- Bottle Label 25 mg - 71610 0260 30
- Figure 1 - 92296151 e507 41b4 a040 c01b87ecb982 01
- figure 2 - 92296151 e507 41b4 a040 c01b87ecb982 02
- figure 3 - 92296151 e507 41b4 a040 c01b87ecb982 03
- figure 4 - 92296151 e507 41b4 a040 c01b87ecb982 04
- figure 5 - 92296151 e507 41b4 a040 c01b87ecb982 05
- figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 06
- figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 07
- Aphena Pharma Solutions - TN - Aphena
Product Label Images
The following 9 images provide visual information about the product associated with Losartan Potassium NDC 71610-260 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Bottle Label 25 mg - 71610 0260 30
Figure 1 - 92296151 e507 41b4 a040 c01b87ecb982 01
figure 2 - 92296151 e507 41b4 a040 c01b87ecb982 02
The text appears to be a graph or chart showing the percentage of patients who achieved the primary endpoint in a study involving Atenolol and Losartan Potassium Tablets. It also shows an adjusted risk reduction of 13% with a p-value of 0.021. The study was conducted for 60-65 months.*
figure 3 - 92296151 e507 41b4 a040 c01b87ecb982 03
This appears to be a comparison of the effectiveness of Atenolol and Losartan Potassium Tablets on patients with fatal or non-fatal stroke. The graph provides data for the adjusted risk reduction of stroke, showing a 25% reduction in risk for the Losartan group compared to the Atenolol group with a p-value of 0.001. The study seems to have been conducted over a period of 68 months, with data points provided for each month within that timeframe.*
figure 4 - 92296151 e507 41b4 a040 c01b87ecb982 04
figure 5 - 92296151 e507 41b4 a040 c01b87ecb982 05
This appears to be a table or chart showing the percentage of patients experiencing an event in different populations. The table also includes a possible measure of risk reduction and a reference to Losartan Potassium Tablets and a Placebo. However, without further context or information, it is not possible to determine the precise purpose or meaning of this information.*
figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 06
figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 07
Aphena Pharma Solutions - TN - Aphena
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
